Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial.
Am J Hematol
; 97(6): E204-E207, 2022 06 01.
Article
in En
| MEDLINE
| ID: mdl-35315128
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Limits:
Humans
Language:
En
Journal:
Am J Hematol
Year:
2022
Document type:
Article
Affiliation country:
Italy